Sp72

PANCREATIC CANCER SCREENING: IS THE JUICE WORTH THE SQUEEZE?

Date
May 18, 2024


Tracks

Related Products

Thumbnail for MULTICENTER STUDY EVALUATING LEARNING CURVES AND COMPETENCE IN COLORECTAL ENDOSCOPIC MUCOSAL RESECTION (C-EMR) AMONG ADVANCED ENDOSCOPY TRAINEES USING AN EMR STANDARDIZED ASSESSMENT TOOL (EMR-STAT): INTERIM ANALYSIS
MULTICENTER STUDY EVALUATING LEARNING CURVES AND COMPETENCE IN COLORECTAL ENDOSCOPIC MUCOSAL RESECTION (C-EMR) AMONG ADVANCED ENDOSCOPY TRAINEES USING AN EMR STANDARDIZED ASSESSMENT TOOL (EMR-STAT): INTERIM ANALYSIS
Training in interventional endoscopy is offered by interventional endoscopy fellowship programs (IEFPs) not accredited by the ACGME. The number of these programs has increased exponentially with a concurrent increase in the breadth and complexity of these procedures…
Thumbnail for CLINICAL EFFICACY AND SAFETY OF A NOVEL OVER-THE-SCOPE GASTRODUODENAL FULL THICKNESS RESECTION DEVICE (GFTRD) FOR THE TREATMENT OF UPPER GASTROINTESTINAL TRACT LESIONS: A LARGE MULTICENTER EXPERIENCE
CLINICAL EFFICACY AND SAFETY OF A NOVEL OVER-THE-SCOPE GASTRODUODENAL FULL THICKNESS RESECTION DEVICE (GFTRD) FOR THE TREATMENT OF UPPER GASTROINTESTINAL TRACT LESIONS: A LARGE MULTICENTER EXPERIENCE
Non-variceal upper gastrointestinal bleeding (NVUGIB) accounts for a significant number of patient visits to emergency rooms and remains a major cause of mortality and morbidity worldwide. The re-bleeding rates of NVUGIB after endoscopic treatment within 72 hours have been reported to be up to 25%…
Thumbnail for PANCREATIC NET, IPMN-RELATED ADC, & PSEUDOPAPILLARY NEOPLASMS HAVE BEEN RAPIDLY RISING IN INCIDENCE AND HAVE BETTER SURVIVAL COMPARED TO OTHER PANCREATIC CANCERS: NATIONWIDE ANALYSIS OF THE US CANCER STATISTICS (USCS) AND NATIONAL CANCER DATABASES (NCDB)
PANCREATIC NET, IPMN-RELATED ADC, & PSEUDOPAPILLARY NEOPLASMS HAVE BEEN RAPIDLY RISING IN INCIDENCE AND HAVE BETTER SURVIVAL COMPARED TO OTHER PANCREATIC CANCERS: NATIONWIDE ANALYSIS OF THE US CANCER STATISTICS (USCS) AND NATIONAL CANCER DATABASES (NCDB)
BACKGROUND AND AIMS: Currently, most patients with branch duct intraductal papillary mucinous neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with questionable benefits regarding cancer prevention…
Thumbnail for IMMUNOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN PATIENTS WITH STAGE IV PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): RESULTS FROM THE NATIONAL CANCER DATABASE (NCDB) 2004-2018
IMMUNOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN PATIENTS WITH STAGE IV PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): RESULTS FROM THE NATIONAL CANCER DATABASE (NCDB) 2004-2018
BACKGROUND: Pancreatic cancer (PC) features highly proliferative cancer cells and a dense stroma modulating tumor growth. Due to the invasive behavior of PC and the lack of effective treatments, there is a pressing need to develop therapies targeted at tumorigenic events to slow down PC progression…